MAPT/Tau/PHF-tau Human Monoclonal Antibody
Anti-Human MAPT/Tau/PHF-tau (BCRPOCD227) is a research-grade recombinant antibody targeting MAPTL. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
MAPTL, Paired helical filament-tau, MTBT1, Microtubule-associated protein tau, TAU, Neurofibrillary tangle protein, MAPT, PHF-tau
UniProt
P10636
Reactivity
Human
Clonality
Monoclonal
Clone
BCRPOCD227
Conjugation
Unconjugated
Field of Research
Neuroscience
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Human
Preservative
0.01M PBS, pH 7.4.
Isotype
IgG
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Cytokeratin, LMW (AE-1), CF647 conjugate, 0.1mg/mL
Mucin 1 / EMA / Episialin / CD227 (VU-2G7), CF405S conjugate, 0.1mg/mL
CD44 Standard (156-3C11), CF594 conjugate, 0.1mg/mL
CD45 / LCA (2B11 + PD7/26), CF568 conjugate, 0.1mg/mL
TACSTD2 / TROP2 (Epithelial Marker) (TACSTD2/2152), CF647 conjugate, 0.1mg/mL
